Related Experiment Video
Updated: Aug 13, 2026

A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human Cells
Published on: August 25, 2017
Targeted gene repair activates Chk1 and Chk2 and stalls replication in corrected cells
Luciana Ferrara1, Eric B Kmiec
1Department of Biological Sciences, University of Delaware, Delaware Biotechnology Institute, 15 Innovation Way, Newark, DE 19711, USA.
Abstract:
Oligonucleotides (ODNs) can direct the exchange of single nucleotides at specific sites in the mammalian genome. It is generally believed that the ODN aligns in homologous register with its complementary site in the target gene and provides a template for the endogenous repair machinery to alter the sequence of the gene. We have been studying the initial phase of the reaction with particular emphasis on the cellular events that occur when the oligonucleotide enters the cell. Our results show that, following introduction of the oligonucleotide, the DNA-damage response pathway is activated, evidenced by the presence of phosphorylated p53, Chk1 and Chk2, respectively. As a result, progression of some of these cells through the cell cycle is slowed and those bearing corrected genes all contain phosphorylated Chk1 and Chk2. In contrast, uncorrected cells contain much lower levels of these proteins in the activated state and pass through the cell cycle in a normal fashion. We suggest that gene repair directed by oligonucleotides activates a pathway that prevents corrected cells from proliferating in cell culture through the activation of Chk1 and Chk2. Our results impact the future use of gene repair for ex vivo gene therapy applications.
Insights
Oligonucleotides (ODNs) initiate DNA repair, activating cellular checkpoints. Corrected cells show high Chk1/Chk2 activation, slowing proliferation, impacting ex vivo gene therapy.
Area of Science:
- Molecular Biology
- Genetics
- Cell Biology
Background:
- Oligonucleotides (ODNs) are used for targeted genome editing.
- The mechanism of ODN-mediated gene repair involves cellular repair machinery.
- Understanding cellular events post-ODN introduction is crucial for gene therapy.
Purpose of the Study:
- To investigate the cellular events following oligonucleotide (ODN) introduction into mammalian cells.
- To elucidate the role of the DNA-damage response pathway in ODN-directed gene repair.
- To assess the impact of gene repair on cell cycle progression and proliferation.
Main Methods:
- Introduction of ODNs into mammalian cells.
- Analysis of DNA-damage response pathway activation (phosphorylated p53, Chk1, Chk2).
- Monitoring of cell cycle progression in corrected and uncorrected cells.
Main Results:
- ODN introduction activates the DNA-damage response pathway, indicated by p53, Chk1, and Chk2 phosphorylation.
- Cells with corrected genes exhibit elevated phosphorylated Chk1 and Chk2, leading to cell cycle arrest.
- Uncorrected cells show minimal activation of these proteins and normal cell cycle progression.
Conclusions:
- Oligonucleotide-directed gene repair activates cell cycle checkpoints (Chk1, Chk2).
- This activation pathway inhibits proliferation of corrected cells in culture.
- Findings have implications for the application of gene repair in ex vivo gene therapy.
More Related Videos
Related Concept Videos
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Restarting Stalled Replication Forks
Homologous Recombination
Negative Regulator Molecules
Fixing Double-strand Breaks

